DERL1
Derlin-1
Also known as: DER-1, DER1, DERL1_HUMAN, derlin-1, FLJ13784, MGC3067, PRO2577
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BUN8
- Gene
- DERL1
- Ensembl
- ENSG00000136986
- Chromosome
- 8
- Canonical length
- 251 aa
- Protein class
- Plasma proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Endoplasmic reticulum
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene is a member of the derlin family. Members of this family participate in the ER-associated degradation response and retrotranslocate misfolded or unfolded proteins from the ER lumen to the cytosol for proteasomal degradation. This protein recognizes substrate in the ER and works in a complex to retrotranslocate it across the ER membrane into the cytosol. This protein may select cystic fibrosis transmembrane conductance regulator protein (CFTR) for degradation as well as unfolded proteins in Alzheimer's disease. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Aug 2012]
Canonical amino-acid sequenceUniProt
251 residues, UniProt reviewed canonical sequence.
>Q9BUN8|DERL1
1 MSDIGDWFRS IPAITRYWFA ATVAVPLVGK LGLISPAYLF LWPEAFLYRF QIWRPITATF
61 YFPVGPGTGF LYLVNLYFLY QYSTRLETGA FDGRPADYLF MLLFNWICIV ITGLAMDMQL
121 LMIPLIMSVL YVWAQLNRDM IVSFWFGTRF KACYLPWVIL GFNYIIGGSV INELIGNLVG
181 HLYFFLMFRY PMDLGGRNFL STPQFLYRWL PSRRGGVSGF GVPPASMRRA ADQNGGGGRH
241 NWGQGFRLGD QLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DERL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 98 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 98 nTPM
- liver: 72 nTPM
- skeletal muscle: 69 nTPM
- adipose tissue: 65 nTPM
- tonsil: 52 nTPM
- appendix: 51 nTPM
Single-cell type
- plasma cells: 255 nCPM
- late primary spermatocytes: 129 nCPM
- esophageal apical cells: 113 nCPM
- pancreatic duct cells: 101 nCPM
- syncytiotrophoblasts: 101 nCPM
- esophageal suprabasal cells: 93 nCPM
Immune cell
- MAIT T-cell: 93 nTPM
- gdT-cell: 90 nTPM
- total PBMC: 83 nTPM
- T-reg: 80 nTPM
- non-classical monocyte: 78 nTPM
- NK-cell: 78 nTPM
Brain region
- choroid plexus: 51 nTPM
- cerebellum: 37 nTPM
- white matter: 36 nTPM
- hypothalamus: 33 nTPM
- cerebral cortex: 32 nTPM
- hippocampal formation: 32 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.12
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 22% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to misfolded protein
- endoplasmic reticulum unfolded protein response
- ERAD pathway
- establishment of protein localization
- positive regulation of protein ubiquitination
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein destabilization
- response to unfolded protein
- retrograde protein transport, ER to cytosol
Molecular functions
- ATPase binding
- identical protein binding
- MHC class I protein binding
- protease binding
- protein-containing complex binding
- signal recognition particle binding
- signaling receptor activity
- ubiquitin protein ligase binding
- ubiquitin-specific protease binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DERL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DERL1 as an antibody target. Whether an autoantibody or antibody against DERL1 could matter depends on whether native DERL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DERL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DERL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...